Area of research
Internal Medicine · Genetics
Research interest
Research interests include Venous Thromboembolism Diagnosis and Management, Myeloproliferative Neoplasms: Diagnosis and Treatment, Atrial Fibrillation Management and Outcomes, and Blood transfusion and management.
Prothrombin complex concentrate for oral factor Xa inhibitor reversal prior to urgent invasive procedures.
Fedratinib for the treatment of myelofibrosis: a critical appraisal of clinical trial and "real-world" data.
The OHI index predicts early mortality from organ dysfunction and survival benefit from etoposide in patients with lymphoma.
Vitamin K Antagonist Anticoagulation in Antiphospholipid Syndrome: Time in Therapeutic Range and Clinical Outcomes.
Weathering the HLH storm and redesigning clinical trials.
Proposals for revised International Working Group–European LeukemiaNet criteria for anemia response in myelofibrosis
Myelofibrosis management in routine clinical practice with a focus on patients with cytopenias: recommendations from a global consensus group.
Queries regarding the two papers each reporting on 1000 essential thrombocythemia patients in BCJ.
Direct Oral Anticoagulants in Special Patient Populations
Challenges in Implementing Guideline on Integrative Oncology and Pain: The Israeli Perspective
Use of direct oral anticoagulants in hematologic malignancies
An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis
COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome
Decision-Making in the Management of Venous Thromboembolism.
D-dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry.
Illustrated State‐of‐the‐Art Capsules of the ISTH 2020 Congress
Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases
Electronic patient identification for sample labeling reduces wrong blood in tube errors
Targeted next generation sequencing for the diagnosis of patients with rare congenital anemias
Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms
Ethnic variation in medical and lifestyle risk factors for B cell non-Hodgkin lymphoma: A case-control study among Israelis and Palestinians
Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients
Azacitidine-lenalidomide (ViLen) combination yields a high response rate in higher risk myelodysplastic syndromes (MDS)—ViLen-01 protocol